Mary P. McGowan

Overview

Mary P. McGowan received an average of $4M in total compensation, including $331K in salary, at Esperion Therapeutics from 2015 to 2017.

Source: SEC filings on April 13, 2018 and March 6, 2017.

Related executives

We found ten more executives who work or worked at Esperion Therapeutics.

Sheldon Koenig

Esperion Therapeutics

Chief Executive Officer

JoAnne Foody

Esperion Therapeutics

Chief Medical Officer

Benjamin Looker

Esperion Therapeutics

General Counsel

Tim Mayleben

Esperion Therapeutics

Chief Executive Officer

Richard Bartram

Esperion Therapeutics

Chief Financial Officer

Ashley Hall

Esperion Therapeutics

Former Chief Development Officer

Mark Glickman

Esperion Therapeutics

Chief Commercial Officer

Narendra DABT

Esperion Therapeutics

Executive Vice President, Research and Development

You may also like